[1]
|
LI S,HU T,LV W,et al.Changes in prevalence and clinical characteristics of cervical cancer in the People's Republic of China:a study of 10012 cases from a Nationwide Working Group[J].Oncologist,2013,18(10):1101. |
[2]
|
CHAMBERS G,MILLAN D,CUSCHIERI K,et al.Assessing the detection of human papillomavirus late mRNA in liquid base cytology samples for risk stratification of cervical disease[J].J Med Virol,2014,86(4):627. |
[3]
|
汪志求,韩光锋,段爱雄.紫杉醇联合顺铂方案同步放化疗治疗中晚期官颈癌近期疗效观察[J].蚌埠医学院学报,2012,37(9):1048. |
[4]
|
吴秋萍,叶金艳,程浩,等.宫颈癌术后HPV持续感染者阴道微生态状况分析[J].中国微生态学杂志,2015,27(10):1210. |
[5]
|
IBRAHIM A,RASCH V,PUKKALA E,et al.Cervical cancer,risk factors and feasibility of acetic acid screening method in Sudan[J].Int J Womens Health,2011,3(6):117. |
[6]
|
BAYO S,BOSCH FX,DES S,et al.Risk factors of invasive cervical cancer in Mali[J].Int J Epidemiol,2015,31(1):202. |
[7]
|
刘国成,赵莉娜.PDGF-A,B在宫颈鳞癌中的表达及临床意义[J].现代医院,2112,12(11):19. |
[8]
|
李峥嵘,李沛隆.宫颈癌发病情况及细胞DNA定量分析技术应用于宫颈癌筛查的临床研究[J].临床医学,2014,33(6):94. |
[9]
|
莫伟杰,吴月莲.细胞DNA定量分析技术在宫颈癌筛查中的应用[J].中国临床新医学,2012,5(3):270. |
[10]
|
周宏,罗新.细胞DNA倍体分析技术在人口大国宫颈病变先行筛查中的优势[J].中国计划生育和妇产科,2016,8(9):11. |
[11]
|
BUYS TP,CANTOR SB,GUILLAUD M,et al.Optical technologies and molecular imaging for cervical neoplasia:a program project update[J].Gend Med,2012,9(1):S7. |
[12]
|
田玉旺,刘光,周建,等.细胞DNA定量分析技术在宫颈癌及癌前病变早期筛查中的应用价值[J].诊断病理学杂志,2013,20(7):425. |
[13]
|
DEMIREL D,AKYVREK N,RAMZY I.Diagnostic and prognostic significance of image cytometric DNA ploidy measurement in cytological samples of cervical squamous intraepithelial lesions[J].Cytopathology,2013,24(2):105. |
[14]
|
杨玉涛,张帆,曾莉,等.细胞DNA定量分析技术在宫颈癌筛查中的回顾性研究[J].中国妇幼保健,2013,28(14):2304. |
[15]
|
SOLOMON D,DAVEY D,KURMAN R,et al.The 2001 Bethesda System:terminology for reporting results of cervical cytology[J].JAMA,2002,287(16):2114. |
[16]
|
SOLOMOND.The 1988 Bethesda System for reporting cervical/vaginal cytologic diagnoses:developed and approved at the National Cancer Institute workshop in Bethesda,MD,December 12-13,1988[J].Diagn Cytopathol,1989,5(3):331. |
[17]
|
KURMAN RJ,HENSON DE,HERBST AL,et al.Interim guidelines for management of abnormal cervical cytology.The 1992 National Cancer Institute Workshop[J].JAMA,1994,271(23):1866. |
[18]
|
PICCOLI R,MANDATO VD,LAVITOLA G,et al.Atypical squamous cells and low squamous intraepithelial lesions in postmenopausal women:implications for management[J].Eur J Obstet Gynecol Reprod Biol,2008,140(2):269. |
[19]
|
LAPIERRE SG,SAUTHIER P,MAYRAND MH,et al.Human papillomavirus(HPV)DNA triage of women with atypical squamous cells of undetermined significance with cobas 4800 HPV and hybrid capture 2 tests for detection of high-grade lesions of the uterine cervix[J].J Clin Mi-Crobiol,2012,50(4):1240. |
[20]
|
WRIGHT TC,COX JT,MASSAD LS,et al.2001 Consensus Guidelines for the management of women with cervical cytologicalabnormalities[J].JAMA,2002,287(16):2120. |